Visceral Leishmaniasis
📧 Sign up to get email alerts when something new happens for Visceral Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study [Phase 2]
A Phase 2 proof-of-concept trial of LXE408 for primary visceral leishmaniasis in Ethiopia has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Human Bioequivalence Study of Amphotericin B Liposome for Injection [NA]
Completed a human bioequivalence study of liposomal amphotericin B for injection.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
A completed study reports the incidence of relapse and Post-kala-azar dermal leishmaniasis in South Sudan among visceral leishmaniasis patie…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study
A proof-of-concept and validation study of a Leishmania antigen rapid diagnostic test for visceral leishmaniasis has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-02-29Clinical Trial Update: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa [Phase 3]
Phase III trial update for miltefosine/paromomycin in treating visceral leishmaniasis in Eastern Africa has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. [Phase 3]
Phase 3 clinical trial update evaluating Ambisome alone and in combination with Miltefosine for treatment of visceral leishmaniasis in HIV-p…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study [Phase 3]
Completed Phase 3 cohort study evaluating pentamidine prophylaxis to prevent relapses of visceral leishmaniasis in HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2018-03-16Clinical Trial Update: A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in Bangladesh [NA]
This document reports the completion of a pilot capacity-building study for a multi-centre randomized trial evaluating treatment for viscera…
-
CLINICAL_TRIALS trial_result · 2017-09-18Clinical Trial Update: A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis. [Phase 2]
Phase 2 clinical trial comparing sitamaquine to amphotericin B for visceral leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil [Phase 4]
A Phase 4 clinical trial evaluating efficacy and safety of drugs for visceral leishmaniasis in Brazil was terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children [Phase 4]
Phase 4 trial evaluating amphotericin B for visceral leishmaniasis in Brazilian children has been completed.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) [Phase 3]
Phase 3 trial evaluating replacement insecticide strategies to control visceral leishmaniasis. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa [Phase 2]
A Phase 2 trial update evaluating safety and efficacy of three regimens—Sodium Stibogluconate with AmBisome, Miltefosine with AmBisome, and …
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) [NA]
A completed study (NIDIAG-Fever) evaluated rapid diagnostic tests and clinical/laboratory predictors to diagnose tropical diseases in patien…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa [Phase 2]
Phase 2 trial evaluated an allometric miltefosine dosing strategy for visceral leishmaniasis in children in Eastern Africa, focusing on phar…
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Miltefosine for Brazilian Visceral Leishmaniasis [Phase 1, Phase 2]
Miltefosine was studied in Phase 1 and Phase 2 trials for visceral leishmaniasis in Brazil (Kala Azar), but the study was terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis [Phase 3]
Phase 3 trial comparing Sodium Stibogluconate, Paromomycin, and their combination for visceral leishmaniasis reports efficacy and safety dat…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers [Phase 1]
Phase 1 study of the LEISH-F3 + SLA-SE vaccine in healthy adults has completed, evaluating safety and immunogenicity related to visceral lei…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh [Phase 3]
A Phase III trial comparing a short-course combination therapy (Ambisome, Miltefosine, Paromomycin) to AmBisome for visceral leishmaniasis i…
-
CLINICAL_TRIALS trial_result · 2016-01-21Clinical Trial Update: Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL [Phase 2]
The Phase 2 open-label safety and efficacy study to determine the optimal single-dose regimen of Ambisome for visceral leishmaniasis has bee…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan [Phase 2]
This clinical trial update concerns a Phase 2 study evaluating fexinidazole for visceral leishmaniasis in Sudan. The study has been terminat…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India [Phase 1]
Phase 1 open-label safety study of a three-antigen Leishmania polyprotein vaccine with MPL-SE adjuvant in healthy adults in India; the trial…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) [Phase 4]
A Phase 4 clinical trial completed in Bangladesh evaluated how different treatment regimens for visceral leishmaniasis, along with host immu…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis [Phase 3]
Phase 3 clinical trial evaluating the safety and efficacy of paromomycin for visceral leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis [Phase 4]
This Phase 4 update reports completion of a study evaluating the safety and efficacy of intramuscular paromomycin for visceral leishmaniasis…